Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity.
暂无分享,去创建一个
D. Longo | W. Alexander | R. Wiltrout | W. Murphy | B. Blazar | B. Curti | A. Soulika | G. Sckisel | M. Bouchlaka | A. Monjazeb | M. Crittenden | Danice E. C. Wilkins | K. Alderson | Can M Sungur | E. Ames | A. Mirsoian | Abhinav Reddy | Can M. Sungur | Annie Mirsoian | Erik Ames
[1] J. Weiss,et al. Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help , 2014, PloS one.
[2] L. Lanier,et al. Influenza infection results in local expansion of memory CD8+ T cells with antigen non‐specific phenotype and function , 2014, Clinical and experimental immunology.
[3] B. Aronow,et al. Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection , 2013, Science.
[4] R. Schreiber,et al. Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling , 2013, Science.
[5] A. Tyznik,et al. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. , 2013, Cell reports.
[6] V. Appay,et al. Monitoring cellular immune markers in HIV infection: from activation to exhaustion , 2013, Current opinion in HIV and AIDS.
[7] A. Singer,et al. IL-7 signaling must be intermittent, not continuous, during CD8 T cell homeostasis to promote cell survival instead of cell death , 2012, Nature Immunology.
[8] W. Urba,et al. Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses , 2012, Science Translational Medicine.
[9] J. Weiss,et al. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. , 2012, Blood.
[10] W. Murphy,et al. Antigen-specific versus Antigen-nonspecific Immunotherapeutic Approaches for Human Melanoma: The Need for Integration for Optimal Efficacy? , 2011, International reviews of immunology.
[11] D. Unutmaz,et al. Revisiting Immune Exhaustion During HIV Infection , 2011, Current HIV/AIDS reports.
[12] M. Fischl,et al. Immune Exhaustion Occurs Concomitantly With Immune Activation and Decrease in Regulatory T Cells in Viremic Chronically HIV-1–Infected Patients , 2010, Journal of acquired immune deficiency syndromes.
[13] M. Mohrs,et al. Sustained signaling by canonical T helper cytokines throughout the reactive lymph node , 2010, Nature Immunology.
[14] H. He,et al. Interleukin‐2 inhibits polarization to T helper type 1 cells and prevents mouse acute graft‐versus‐host disease through up‐regulating suppressors of cytokine signalling‐3 expression of naive CD4+ T cells , 2010, Clinical and experimental immunology.
[15] N. Restifo,et al. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. , 2009, Trends in immunology.
[16] B. Comin-Anduix,et al. Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma , 2008, Journal of Translational Medicine.
[17] Masato Kubo,et al. SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.
[18] J. Weiss,et al. IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy , 2007, Nature Medicine.
[19] C. Nguyen,et al. STAT5-Mediated Signals Sustain a TCR-Initiated Gene Expression Program toward Differentiation of CD8 T Cell Effectors1 , 2006, The Journal of Immunology.
[20] J. Sprent,et al. Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes , 2006, Science.
[21] S. Rosenberg,et al. Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study , 2005, Annals of Surgical Oncology.
[22] S. Rosenberg,et al. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Bevan,et al. Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help , 2003, Science.
[24] J. Wigginton,et al. Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses 1 , 2003, The Journal of Immunology.
[25] F. Sallusto,et al. Cytokine-driven proliferation and differentiation of human naïve, central memory and effector memory CD4+ T cells. , 2003, Pathologie-biologie.
[26] R. Schwartz. T cell anergy. , 1993, Scientific American.
[27] S. Rowland-Jones,et al. Premature ageing of the immune system: the cause of AIDS? , 2002, Trends in immunology.
[28] F. Sallusto,et al. Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T Cells , 2001, The Journal of experimental medicine.
[29] G. Bray,et al. Constitutive activation of STAT-3 and downregulation of SOCS-3 expression induced by adrenalectomy. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[30] J. Sprent,et al. Stimulation of naive and memory T cells by cytokines , 1999, Immunological reviews.
[31] Aaron J. Johnson,et al. Prevalent Class I-Restricted T-Cell Response to the Theiler’s Virus Epitope Db:VP2121–130 in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28 , 1999, Journal of Virology.
[32] J. Ihle,et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. , 1999, Immunity.
[33] J. Altman,et al. Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[35] F. Alt,et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.
[36] R. Ahmed,et al. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.
[37] S. Jonjić,et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.
[38] R. Schwartz,et al. Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.